Navigation Links
MannKind Corporation Reports Second Quarter Financial Results
Date:8/11/2008

of 2008 as compared to the same period in 2007. The increase in G&A expenses for the first six months was primarily due to increases in salary related expenses and stock-based compensation expense, partially offset by lower professional service fees.

We expect G&A expenses to increase during the remainder of 2008 as a result of increased salary and stock-based compensation related expenses and professional service fees.

The net loss for the second quarter of 2008 was $79.8 million, or $0.79 per share, based on 101.4 million weighted average shares outstanding. This compares to a net loss of $72.0 million, or $0.98 per share, based on 73.4 million weighted average shares outstanding for the second quarter of 2007.

The net loss for the first half of 2008 was $151.2 million, or $1.49 per share based on 101.4 million shares outstanding, compared with a net loss of $145.1 million, or $1.98 per share based on 73.4 million shares outstanding, for the first half of 2007.

Cash and cash equivalents were $180.5 million at June 30, 2008, $269.1 million at March 31, 2008 and $368.3 million at December 31, 2007.

"This is an exciting time for MannKind Corporation," commented Alfred Mann, Chairman and CEO. "We are only about three weeks from completion of our final two pivotal trials for Technosphere Insulin. Importantly, our team was satisfied with the outcome from our July 14 pre-NDA meeting with the FDA. Our science, preclinical and clinical programs have enabled us to target year-end to complete preparation of the NDA, though that is an aggressive target."

Hakan Edstrom, President and COO, added, "Our new Danbury factory is virtually complete and we are looking forward to the dedication on September 17. This factory is being equipped in modular steps to meet our expected demand for Technosphere Insulin. Our other products are also moving forward, and clinical progress for our GLP-1 formulation and two cancer vaccines continues to be ve
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. MannKind Corporation to Hold Second Quarter Financial Results Conference Call on August 11, 2008
2. MannKind to Present at Upcoming Conferences
3. MannKind Corporation Reports First Quarter Financial Results
4. MannKind to Present at the Morgan Stanley Healthcare Conference
5. MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 5, 2008
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. MannKind Corporation Response to Recent Market Events
8. MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call on March 4, 2008
9. MannKind to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
10. MannKind to Present at the Wachovia 2008 Healthcare Conference
11. MannKind to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...l/ -- Wyeth (NYSE: WYE ) today,announced that M...esident,Technical Operations & Product Suppl...or all aspects of technical operations and product...BioPharma, Vaccine, Consumer Healthcare,and Nutri...ho has been,appointed to the new role of Executiv...
(Date:11/20/2008)...reen," a new television documentary on The Di...chnology and on-site laboratories at Lake Erie Bio...ocus) November 20, 2008 -- Lake Erie Biofuels, LL...duction facility, is the leading producer of biodi...on be introduced to millions of households nationw...
(Date:11/20/2008)...- Neurocrine Biosciences, Inc.,(Nasdaq: NBIX ) ...hief,Executive Officer of Neurocrine Biosciences ...ay Health Care Conference in New York. , Th...esday, December 2,2008 at 1:30 p.m. Eastern Time...tion will be simultaneously webcast and may be acc...
(Date:11/20/2008)...ll/ -- Hologic, Inc.,(Nasdaq: HOLX ), a leading...diagnostics, medical imaging systems and surgical ...s of women, today announced the Company will host ... who will be attending the RSNA,(Radiological Soc... This meeting will be held on Tuesday, Decembe...
Breaking Biology Technology:Wyeth Names Michael Kamarck President, Technical Operations & Product Supply 2Discovery Channel to Feature Lake Erie Biofuels, LLC 2Discovery Channel to Feature Lake Erie Biofuels, LLC 3Hologic, Inc. to Host Investor Reception at the RSNA Trade Show 2
...s. -- Network Health Plan , Affinity Health Syste... and HealthTrio announced today the availability...s, employers and brokers through HealthTrio connec...NHP will launch the product suite in two phases, b...g this summer, NHPs providers will be able to exch...
...p is the living legend with one of the greatest su...hat fits like a glove his personality and his busi...l marketer with a great personality and now with t...V shows series, wants to own the term Youre fired....ity of our business protocols is still a sheet of ...
...ntrepreneurs located in Wisconsin will have a shot...cond annual Wisconsin Entrepreneurs Conference, wh...sconsin Innovation Network will hold June 1 and 2...ers recently began to call for nominations for the...e. , ,"Wisconsin needs more innovators who ,seize ...
...eaking to a home-state crowd last week, Health and... how his agency touches Americans in unseen ways e...hey take to administering their Medicare accounts ..., ,We just want you to eat less of it (food), joke...shed 15 pounds in his personal quest to lead a hea...
Other Biology Technology:"You're fired!" Trump wants trademark rights 2New Seize the Day award available to Wisconsin entrepreneurs 2Americas weighty problem: Why the fight against fat is about more than just looking good 2Americas weighty problem: Why the fight against fat is about more than just looking good 3
(Date:11/21/2008)...n Halkier, Department of Plant Biology and Biotech... of Copenhagen, has been granted the Danisco Award...excellent research into secondary metabolites, whi...ance, plants. In particular, her research has foc...sport of glucosinolates in cruciferous plants. ,...
(Date:11/20/2008)...wth from Operations in Third Quarter , , JE...METRX, Inc. (OTC Bulletin Board: BMRX), a leading ...ducts, today announced its financial results for t... Revenues for the third quarter were $431,840, whi...revenues of $100,000. , , -- The Company a...
(Date:11/20/2008)...ical Institute at St. Joseph,s Hospital and Medica... motions and the perception of illusory motion tha...nik, PhD, director of the Laboratory of Behavioral...ctor of the Laboratory of Visual Neuroscience; Xoa...cted a study based on the Enigma painting, a visua...
(Date:11/20/2008)...hates strangers. When its security patrol spots a ...roblem when people with type 1 diabetes undergo hu...om a donor pancreas produce robust amounts of insu...ence from insulin therapy. However, the immune sys... A person who has the transplant procedure must ta...
Breaking Biology News(10 mins):The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results 2Researcher tricks immune system in diabetic mice 2Luczo Dragon IndyCar Carries Eyes on the Road Logo to Prevent Blindness to Indy 500 19892 1Luczo Dragon IndyCar Carries Eyes on the Road Logo to Prevent Blindness to Indy 500 19892 2Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 1Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 2Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 3Forty Two Free Clinics Across State Share 241 Million in Grants From Blue Cross Blue Shield of Michigan 19889 4Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 1Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 2Elseviers Engineering Village Search Platform Combines the American Geological Institutes Georef Database With Google Maps 5544 3Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 1Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 2Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 3Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 4Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 5Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 6Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 7Cimzia 28R 29 Provides Long Term Efficacy with Stable Dosing in Crohns Disease 2140 8
...ceptor through which a group of life-threatening h...,s cells, and show that infection can be inhibited...blished online by the journal Nature on February 7...renaviruses, suggest a way of reducing the severit...needed treatment strategy. , The four viruses, kn...
...mmercial farming of salmon in the 1960s, the indus...s expanded to such a degree that prices for farmed...farmed fish may become the next invasive species. ...t become an invasive species in British Columbia, ...t Peter Bisson. "Net pen culture of salmon is big ...
... Journal of the National Cancer Institute quanti...rs developing specific subtypes of soft tissue sar...s after the original retinoblastoma diagnosis. The...cal surveillance for these patients, the authors s...na that primarily affects children and is most oft...
...s responsible for stimulating the appetite make su...reported in the January issue of the journal Cell ...omplex series of molecular events that keep those ... between active thyroid hormone in the brain and i...osts the number of power-generating mitochondria i...
Other Biology News:Discovery could lead to better control of hemorrhagic fever viruses 2Discovery could lead to better control of hemorrhagic fever viruses 3Farmed salmon could become an invasive species in forest streams 2Study examines risk of soft tissue sarcomas in hereditary retinoblastoma survivors 2How appetite-stimulating brain cells work overtime during fasting 2How appetite-stimulating brain cells work overtime during fasting 3
Rab1A
Rat polyclonal to acetyl Salicylic Acid ( Abpromise for all tested applications).
Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798
GBL Antibody
Biology Products: